Author

A. Andrade

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Gomez· 1 shared A. Oaknin· 1 shared A. Vidal· 1 shared A. Villanueva· 1 shared A. Villarrubi· 1 shared D. Trastulli· 1 shared E. Pros· 1 shared J. F. Martin-Tejera· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Gomez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade

O. A. Romero, A. Villarrubi, J. J. Alburquerque-Bejar, A. Gomez, A. Andrade, D. Trastulli, E. Pros, S. Verdura, L. Farre, J. F. Martin-Tejera, P. Llabata, A. Oaknin, M. Saigi, J. M. Piulats, X. Matias-Guiu, , M. Sanchez-Cespedes

This study identifies KDM6A/UTX and KDM6B/JMJD3 as therapeutic targets in SMARCA4-deficient cancers, showing that their inhibition reduces tumor viability in mouse models.

bioRxiv · Aug 7, 2020Cancer Biology